Retatrutide (GLP-3) is a triple agonist research compound targeting GLP-1, GIP, and glucagon receptors simultaneously. A next-generation compound under active investigation.
For in vitro laboratory research use only. Not FDA-approved. Not for human or animal consumption. Not a drug, supplement, or medical device. By purchasing you confirm you are 18+ and a qualified researcher. Full Disclaimer · Terms
